Cancer cachexia
Treating cancer cachexia to treat cancer
5
NF κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
16
Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning
8
THE EFFECT OF OPHIOCEPHALUS STRIATUS EXTRACTS ON TUMOR NECROSIS FACTOR-α (TNF-α) SERUM IN CANCER CACHEXIA PATIENTS
6
Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia
8
The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
9
An enquiry into the metabolic basis of cancer cachexia using Walker 256 carcinosarcoma
424
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
10
ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments
12
IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway
14
Potential role of immunological factors in early diagnosis of cancer cachexia in C26 tumor-bearing mice
9
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse
16
Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis
9
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia
12
<p>Cancer Cachexia: Definition, Staging, and Emerging Treatments</p>
9
Bone mineral density and content are differentially impacted by aerobic and resistance training in the colon-26 mouse model of cancer cachexia
10
Suramin interferes with interleukin 6 receptor binding in vitro and inhibits colon 26 mediated experimental cancer cachexia in vivo
9
Evidence for the involvement of interleukin 6 in experimental cancer cachexia
5
Tumor necrosis factor alpha mediates changes in tissue protein turnover in a rat cancer cachexia model
8
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
19